Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Trianni, Inc. and Antibody Solutions jointly announced that Antibody Solutions has entered into a license agreement with TRIANNI for use of The Trianni Mouse™, a best-in-class fully humanized transgenic mouse platform, to support its therapeutic antibody discovery programs. "We're thrilled to take our partnership with Antibody Solutions to the next…

Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced the initiation of the PULSAR Phase 2 trial of sotatercept for the treatment of patients with pulmonary arterial hypertension (PAH), a chronic and life-changing disease that can…

BIOASIS TECHNOLOGIES INC and WUXI BIOLOGICS today announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer. Bioasis is a biopharmaceutical company developing xB3, a proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and…

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for its leading respiratory pipeline candidate Ryaltris™ (rye - al' - tris), an investigational fixed-dose combination nasal spray of an antihistamine and a steroid,…

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. ("Curevo"). The newly established Seattle-based company's goal is to support GC Pharma's vaccine development activities. GC Pharma builds a strategic collaboration and partnership with global health organizations IDRI (Infectious Disease…

Aquestive Therapeutics, Inc., today announced a settlement agreement has been reached resolving patent litigation related to SUBOXONE® (buprenorphine and naloxone) Sublingual Film. Indivior PLC and its U.S. subsidiary, Indivior Inc., marketers and distributors of SUBOXONE®, joined partner Aquestive in the settlement with Par Pharmaceuticals, Inc., an operating company of Endo…

Harness the true value of digital health at Oxford Global’s Digital Health and Digital Technologies Congress on the 20-21st September 2018 in London, UK. Part of Oxford Global’s ‘Pharmatec Series’ the congress is co-located with the esteemed 16th Annual Pharmaceutical IT Congress and 2nd Annual Artificial Intelligence in Drug Development…

Join Oxford Global’s 16th Annual Pharmaceutical IT Congress on the 20–21 September 2018, London, UK, to discuss how to harness the value in your data and improve business outcomes. The key congress within our ‘PharmaTec Series’ of events, this congress will give you actionable insights into the latest in Big…

We are pleased to present the latest agenda for the 2nd Annual Artificial Intelligence in Drug Development Congress , taking place on 20–21 September 2018 in London, UK. Showcasing over 30 presentations and bringing together over 200 industry leaders, this event is the place to debate the hot topics in…

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, today announced the launch of its product Vesele®, approved by Health Canada for the increase in vasodilation through nitric oxide production,…

loader